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Abstract 
Prediction of metabolism in cytochrome P450s remains to be a crucial yet 
challenging topic in discovering and designing drugs, agrochemicals and 
nutritional supplements. The problem is challenging because the rate of 
P450 metabolism depends upon both the intrinsic chemical reactivity of the 
site and the protein-ligand geometry that is energetically accessible in the 
active site of a given P450 isozyme.  We have addressed this problem using 
a two-level screening system. The first level implements an empirical QSAR-
based scoring function employing the local chemical motifs to characterize 
the intrinsic reactivity. The second level uses molecular docking and 
molecular mechanics to account for the geometrical effects, including 
induced-fit effects in the protein which can be very important in P450 
interactions with ligands. This approach has achieved high accuracy for both 
the P450 3A4 and 2D6 isoforms. In identifying at least one metabolic site in 
the top two ranked positions, the prediction rate can reach as high as 92.7% 
for the test set of isoform 3A4. For the 2D6 isoform, 100% accuracy is 
achieved on this basic evaluation metric, and, because this active site is 
considerably smaller and more selective than 3A4, very high precision is 
attained for full prediction of all metabolic sites. The method also requires 
considerably less CPU time than our previous efforts, which involved a large 
number of expensive simulations for each ligand to be evaluated.  After 
screening using the empirical score function, only a few best candidates are 
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left for each ligand, making the number of necessary estimations in the 
second level very small, which significantly reduces the computation time. 
 
 
1. Introduction 
Metabolism in P450 has crucial impacts on the bioactivity and the safety 
profiles of drug candidates.  On one hand, P450 can convert compounds into 
a modified form that may interact differently with the drug target. On the 
other hand, it can also convert compounds into inactive excretable 
metabolites. Furthermore, P450 metabolism may lead to toxicity from 
unwanted products, causing failures in drug development. It is also relevant 
to many other important issues such as food-drug, drug-drug interaction and 
personalized medication.[1-3] 
 
Predicting the drug metabolism in P450 is a very challenging topic for the 
following reasons. The first is due to the structural diversity of the P450 
isoforms. The active site size varies considerably in different isoforms, e.g 
3A4 (1386Å3)[4] and 2D6 (~540 Å3)[5].  The corresponding binding motifs 
are also quite different, e.g. in 2D6, the GLU216 and SER304 in the great 
majority of relevant cases forms a salt bridge with a positively charged 
nitrogen of the ligand, whereas 3A4 binds a wide range of ligands, and has 
no one feature of the active site that provides substantial geometric 
restriction. The second is that there are many possible reaction pathways 
that can be followed during the P450-catalyzed oxidation of the reactant. A 
recent review summarized the possible pathway of clinically used drugs 
which can be metabolized in the P450 1, 2 and 3 families.[6] A total of 248 
pathways were proposed. One pathway can happen in several isoforms, 
which leads to some isoforms having as high as 148 possible pathways for 
the clinically used drugs, such as 3A4. Thirdly, there are certain reaction 
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pathways that involving electron transfer in conjugated groups, which makes 
prediction even more difficult.[7] 
 
Due to the challenges and resource requirement to study the metabolism 
experimentally[6], substantial efforts have been devoted to develop in silico 
method to study P450 metabolism[8, 9] , such as  the commercially 
available programs Metasite[10] and StarDrop[11]. Depending upon the 
input information that is to be utilized, there are generally three types of 
computational approaches:  ligand-based, structure-based and mixed 
approaches.  
 
Ligand-based methods makes predictions based on estimated hydrogen 
abstraction energies [12, 13]and they are usually combined with a heuristic 
attempt to take into account the ability of the ligand to bind to the P450 
active site. Enzyme information may be incorporated to get improved 
results.[14, 15].  If a large training set is used, these methods can yield 
respectable results.[13, 15, 16] For example, RegioSelectivity-Predictor(RS-
Predictor)[17, 18] uses topological and quantum chemical descriptors to 
represent the reactivity of potential metabolic site. However, due to the 
highly approximate consideration of the protein-ligand binding process, the 
precision and robustness of these approaches are limited, and it is difficult to 
increase accuracy beyond a given point. 
 
On the other hand, structure based methods generally perform a thorough 
conformational search to generate the best possible poses, using molecular 
docking programs such as Glide[19], AutoDock[20] etc. Induced fit effects, 
that is, taking into account protein flexibility,  are usually needed in such an 
approach to generate good results for mammalian P450 isozymes, which in 
general have a considerable degree of receptor flexibility upon ligand 
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binding. However, the use of single protein structure in conjunction with a 
rigid receptor docking algorithm may leads to an inability to fully incorporate 
induced fit effects. Ensemble docking[21] can mitigate the problem of single 
protein structure by allowing docking a single ligand library against multiple 
rigid receptor conformations. Considerable evidence show that ensemble 
docking can improve the docking results. The improvement depends on the 
methods used to create the ensemble, the ensemble size and the scoring 
functions used in docking.   
 
Mixed methods use both the reactivity calculation and conformational search 
to predict the site of metabolism. One way of combining reactivity 
information and structural information would be designing a scoring function 
which contains both the binding energy and the intrinsic reactivity. Highly 
accurate results can be generated in certain isoforms, such as our previous 
attempt on 2D6.[22] However, using a single scoring function requires 
highly accurate calculation of both the binding energy and intrinsic reactivity. 
Thus, the computational time may pose a problem.  At the same time, an 
accurate estimation of the intrinsic reactivity would be a challenging task 
itself for the ligands where multiple reaction pathways would take place on 
certain sites.  Finally, for 3A4, the size and complexity of the active site 
poses a severe challenge to a heavily physics based method. The 
incorporation of some empirical information based on a training set, while 
possibly reducing the generality of the methodology, enables the use of less 
demanding simulations, which is essential in bringing the CPU time for 3A4 
calculations into the realm of practical applications.  
 
The method described in the present work combines both ligand and 
structure based methods to generate an effective prediction approach. To 
mitigate the problem of computation time and the problem of multiple 
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reaction pathways, a two-stage screening system is employed. The key is to 
locate a site of the ligand which possesses good reactivity and has an 
acceptable structure based binding energy in a suitably chosen induced fit 
pose. Considering the computational time required for accurate calculation of 
binding energies, the present work uses the reactivity as the first stage of 
screening. Unlike the traditional physics based methods of estimating the 
intrinsic reactivity, which attempt to calculate the reaction barrier of the 
ligand oxidation using for example quantum chemistry, the current method 
divides the candidates into different reaction groups with each group having 
similar reactivity. Only the candidates in the sufficiently highly reactive 
groups are passed on to the stage where relative binding energy is 
estimated, thus substantially reducing the required computational effort. As 
is shown below, this method achieves both high accuracy and high efficiency.   
 
The paper is organized as following: the detailed methodology is provided in 
section 2; section 3 focuses on the results for 3A4 and 2D6; in section 4, the 
key functional groups for intrinsic reactivity, and induced fit effects are 
discussed; section 5 gives the conclusions and the directions of future work.  
We compare our 2D6 results to our own previous work [22] and 
demonstrate that the new approach achieves very similar levels of accuracy 
(including a false positive rate that is at least an order of magnitude better 
than alternative approaches in the literature) while reducing computation 
time substantially.  We further investigate 3A4 because of its central 
importance in drug metabolism (~60% of metabolism is due to 3A4 for 
known drugs), and because of the great challenge of treating its large, 
exceptionally flexible active site; there was a real possibility that structure 
based methods simply would not be helpful for 3A4 metabolic predictions. 
We show that this is not the case, and that the induced fit docking step 
improves accuracy by ~10-15%; not as dramatically as for 2D6, but enough 
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to make a measurable, and useful, difference. Furthermore, the present 
approach provides structures (which using present technology cannot be 
obtained experimentally) which may have utility in lead optimization efforts 
when there is a metabolic problem with a drug candidate. 
 
 
2. Methods 
The present work uses a series of hierarchical filters to search for the best 
sites of metabolism of the ligand. In the previous combined method to 
predict the site of metabolism in P450 that we developed, prediction of 
intrinsic reactivity and binding energy are both required to maintain 
accuracy. The current approach is also based on the intrinsic reactivity and 
binding energy. However, instead of combining the binding energy with 
intrinsic reactivity (IR) directly to produce a single overall scoring function, 
as was done previously, our new method constructs a series of filtering 
processes based on the IR of each potential site and the corresponding 
binding energies. 
 
In the first level of filtering, the IR of each potential site of the ligand is 
calculated using a very rapid empirical scoring approach, discussed below in 
some detail. In our previous work on 2D6, we employed an approximate 
quantum chemical methodology, which was reasonably successful. However, 
the extension of such an approach to 3A4 has potential pitfalls. As 
mentioned previously, there are many possible reactive pathways to be 
considered; the number of such pathways is multiplied in 3A4 where 
geometric restrictions are much less severe than they are in 2D6. 
Furthermore, some possible pathways, especially those involving conjugated 
chemical functional groups, pose additional challenging to the binding energy 
estimation. In those pathways, the closest site to the oxo may not be the 
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final site that has been oxidized. Therefore, it is difficult to build a direct 
relationship between the docked pose and the potential site of metabolism.  
 
Many computational efforts have been tried or proposed to overcome these 
issues.[8]In the present paper, our method uses a score function, which 
characterizes the IR based on the local chemical motif. This is based on the 
assumption that the local chemical motif is the main factor that decides 
which pathway the potential site will choose and also the main factor that 
characterizes the reaction barrier for the potential site. Therefore, a method 
to characterize the functional group in the local motif of each potential site of 
metabolism and an approach to characterize the potential contribution of 
each functional group are required. The local motif reactivity score 
(𝑙𝑜𝑐𝑎𝑙_𝑚𝑜𝑡𝑖𝑓_𝑅𝑆) function is then designed to address the above two issues. 
In this model, the reactivity of the target site of metabolism (SOM) is solely 
decided by the local chemical motif of that target site. The local chemical 
motif is characterized by three classes of functional groups: the primary, the 
secondary and the correctional functional groups. The primary functional 
groups are used to describe the immediate environment of the target SOM 
atom, and it is directly associated with chemical features, such as number of 
connected hydrogen atoms, aromatic properties etc. The secondary 
functional groups are used to describe the chemical groups directly 
connected to the target SOM, such as positive charged nitrogen, carbonyl, 
and benzene et.al. The correctional functional groups are used to describe 
the additional functional groups connected to the target SOM or the 
secondary functional groups. The overall reactivity score 𝑙𝑜𝑐𝑎𝑙_𝑚𝑜𝑡𝑖𝑓_𝑅𝑆 of the 
target SOM is then calculated based on the following formula: 
 𝑙𝑜𝑐𝑎𝑙_𝑚𝑜𝑡𝑖𝑓_𝑅𝑆 = 𝑃𝑟𝑖𝑚𝑎𝑟𝑦_𝑅𝑆 + 𝑆𝑒𝑐𝑜𝑛𝑑𝑎𝑟𝑦_𝑅𝑆 + 𝐶𝑜𝑟𝑟𝑒𝑐𝑡𝑖𝑜𝑛	_𝑅𝑆 𝑃𝑟𝑖𝑚𝑎𝑟𝑦_𝑅𝑆, 𝑆𝑒𝑐𝑜𝑛𝑑𝑎𝑟𝑦_𝑅𝑆 and 𝐶𝑜𝑟𝑟𝑒𝑐𝑡𝑖𝑜𝑛_𝑅𝑆 are the reactivity score assigned 
to the primary, secondary and correctional functional groups of the target 
SOM.  
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All the functional groups included in the model are identified from the 
published experimental results and the proposed mechanisms[23-26]. For 
the primary functional groups, the element carbon (C), nitrogen (N), 
phosphorus (P) and sulfur (S) are considered as the potential SOM. Most of 
the experimental observed SOM has the element of C. Therefore, most of 
the primary functional groups are carbon based.  The carbon based primary 
functional groups are then characterized by number of connected hydrogen 
atoms, whether the target atom is in aromatic ring or not and if the target 
atom is in certain ring structures. The nitrogen based primary functional 
groups are further divided based on number of connected hydrogen atoms 
and also if the target nitrogen is in aromatic structure or not. For the sulfur 
based primary functional groups, only sulfur with oxidation number less than 
+4 are considered as the potential SOM. These functional groups are only 
further divided depending on whether the sulfur is in an aromatic ring. For 
the phosphorus related functional groups, only phosphorus atoms connected 
with sulfur atom are considered as potential SOM.  
 
All the secondary functional groups are constructed based on the potential 
reaction mechanisms for the target potential SOM. There are several 
reviews[26], which provide excellent summary of the possible reaction path 
for each type of chemical motif. In the current method, the secondary 
functional groups are divided into the following four categories: (1) columbic 
attraction type; (2) conjugated group; (3) lone pair group; (4) specific 
structure.  The columbic attraction type mainly composes of positively 
charged nitrogen. Many experimental observed SOMs are near the positively 
charged nitrogen, for example, chloroquine[27], citalopram[28], 
clozapine[29] et.al. One explanation of this could be that the positive charge 
on the nitrogen can form a salt bridge like structure with the negatively 
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charged oxo, therefore stabilizing the docked structure. However, the 
nitrogen atom may actually join the reaction in a neutral state and provide 
an electron to the oxo, such as N-dealkylation reactions. For this reason, all 
the nitrogen atoms, which are not in conjugated systems, are considered to 
belong to the same functional group. The conjugated groups are the most 
complicated type of chemical groups. This category can facilitate the reaction 
by help the electron transfer process through conjugated pi bond. For 
example, the primary metabolic site of testosterone [30] is connected with a 
carbon double bond, which is further conjugated with a carbonyl group. The 
lone pair groups of the carbonyl can help the carbon form a stable radical, 
therefore facilitating the radical based reactions. For example, the true 
positive site of BDB[31] has two oxygen atoms connected. The last type of 
group is the chemical motifs with specific structures. Most of these specific 
structures consist of a ring structure, e.g. 1,8-cineole[32]. The detailed 
information on how this kind of structure may affect the oxidation process is 
unclear. In the current study, there is only a few of this type of functional 
groups considered.  
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Figure 1: Examples of the different type of secondary groups. The color scheme is: red(oxygen), 
white(hydrogen), blue(nitrogen), grey(carbon). All the groups are highlighted in tube.  Upper left: the 
columbic attraction type, a positive charged nitrogen in venlafaxine is highlighted; Upper right: the 
conjugated type, organic amide group in NN_dimethyl_M_toluamide is shown; lower left: the lone pair 
type, an oxygen in the beta_arteether is shown; lower right: the specific structure type, a five-
member ring is highlighted.  
 
The correctional groups are similar to the secondary groups. They are added 
to describe the target atom mainly in the following two conditions, (1) the 
target atom connected to more than one functional group; (2) the functional 
group is conjugated with secondary functional groups. The only exception to 
the above two conditions is that, when a nitrogen related functional group is 
taken as the secondary group, then the nearby oxygen atom within 2 bonds 
will be considered as a correctional group. For the first condition, if more 
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than two functional groups are directly connected, only the two with the top 
two strongest effects are considered.  
 
		
Figure 2:  Example of the correctional groups. Red circle: the target atom. Yellow circle: the secondary 
group. Tube: the correctional group.  Left: the correctional group is directly connected with the target 
atom in benzphetamine. Right: the correctional group is conjugated with the secondary group in 
budesonide.  
 
Only the moieties that are believed to be able to substantially change the 
reactivity of the target SOM are considered. When constructing the groups, 
we tried to use small functional groups or break the large functional groups 
into small pieces with the aim of increasing transferability and generality. 
This would leads to some kinds of unwanted combinations. Therefore, not all 
combinations of different types of primary, secondary and correctional 
functional groups are considered. All of the groups considered in the case of 
3A4 are summarized in the supplemental material. 
 
The groups are further organized into 16 classes. For all the groups in the 
same class, identical score is assigned. Therefore, in this method, there are 
only 16 parameters needed. In addition, since only the ranking is important, 
each parameter is designed to pick a level from 40 levels. Thus, this method 
has a very small solution space for the parameters, helping to reduce 
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potential over-fitting. One more effort to reduce overfitting is that we assign, 
prior to numerical optimization, a high score to certain groups, which are 
highly reactive, and do not change this value during the optimization 
process.  
 
In the second stage, all the candidates in the top 2 categories from the first 
stage are further refined. This refinement process requires molecular 
docking, geometric sampling of the protein active site side chains, and 
minimization of the protein-ligand complex,  to account for the induced fit 
effects. In the molecular docking stage, constraints were added to make 
sure that there are reasonable candidates in the neighborhood of the iron-
oxo complex. Two types of constraints were used to match the needs of 
different type of isoforms. For the isoforms with large active site size, such 
as 3A4, a constraint that specifies each possible candidate SOM (by 
constraining the distance of the target atom to the ferryl oxygen) is used. 
The purpose here is to make sure that each possible candidate will have a 
corresponding geometric structure that can goes to the geometric 
optimization. The reason is that a large number of possible pose can be 
generated, given the large size of the active site. Due to this reason, it is 
difficult to set an arbitrary cut-off, e.g. number of poses, which will ensure 
all the candidates can have a corresponding structure. For the isoform with 
relatively small active site sizes, such as 2D6, a general constraint that only 
requires one heavy atom in the neighborhood of the iron-oxo is used. The 
consideration behinds this is that it will require a great deal of computational 
time to fulfill the first type of constraints in a small active site.  
 
For the structural optimization, the Protein Local Optimization Program 
(PLOP, known as  Prime in Schrödinger Package)[33] software package is 
used. The optimization begins with a structural minimization followed by 
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hybrid Monte Carlo sampling. The structural minimization will minimize the 
ligand as well as the active site region of the protein. The hybrid MC 
sampling consists of multiple parallel simulations, as in our prior 
methodology.[22] In that work, three types of randomized movements were 
considered: side-chain torsional rotations, rigid-body movements of the 
ligand, and molecular dynamics trajectories, all using the continuum 
solvation model in PLOP.  In the present work, the rigid body movements 
are not used due to its low acceptance ratio and relatively long sampling 
time. After the first stage screening, only a small number of candidates are 
selected to go through the second stage of screening. Computational 
experiments have shown that, using our new filtering algorithm, less 
extensive simulations can be employed in the structural optimization 
component of the algorithm (as well as fewer simulations being required). 
These modifications to the algorithm results in a dramatic decrease in 
computation time per ligand, as compared to our prior approach.  
 
The side-chain movements are used to sample the selected side-chain 
conformation of the protein and the ligands by varying the dihedral angles of 
the rotatable bonds. In each movement; up to three close residues are 
allowed to rotate their side chains. The new rotational conformations are 
constructed through random perturbation or pre-defined rotamer libraries. If 
the random perturbation is used, the change of each dihedral angle is the 
sum of a large rotation and a small rotation. The large rotation is N*60 
degrees in which N is a random integer from 0 to 5. The small rotation is a 
random number from 0 to 30 degrees. If the rotamer library is used, a 
random rotamer from a high resolution side-chain library for protein residues 
[34] and from a library of 10 degree resolution for ligand are used to create 
a new conformation. The new structure, with acceptably low van der Waals 
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clashes with other protein atoms, is then minimized and subjected to the 
acceptance criteria.  
 
The hybrid MC[35] movements sample the conformation space of the 
selected residues in the protein and the ligand. A 5 picosecond, constant 
energy molecular dynamic (MD) simulation is performed to generate the new 
structure. In the MD simulation, the RESPA based integration of short range 
forces is used with a time step of 1 femtosecond while the long range forces 
are updated every five steps using Verlet integration[36]. 
In all the sampling steps, distance and angle constraints are applied to the 
target atom to make sure the target atom is in a reasonable region of the 
active site. Detailed information is shown in Figure 3 and 4.  
	
Figure 3: The constraint applied on the non-aromatic target. The color scheme is: pink(oxygen), 
white(hydrogen), yellow(sulfur), aquamarine(iron), green(carbon on the ligand), grey(carbon in the 
heme ring and protein). Left: the distance constraint (2.5±0.5Å) applied to the target atom and the 
virtual oxo, represented by the red dashed line. Right: the angle constraint (145±20O) applied to the 
target, represented by the red solid line. 
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Figure 4: The additional distance constraints (2.8±0.5Å) applied on the aromatic target. The color 
scheme is the same as that in Figure 3. The two distance constraints are applied to the two nearby 
atoms, as represented by the red dashed line.    
 
The final step in the current work is evaluation of the predictive power of the 
methodology, that is, agreement between experimental measurement of the 
SOM and the computational ranking of the various ligand sites .Two types of 
metrics are used in the evaluation process, the top metric (top 1 and 2) and 
the exact number of true positives (TP), false positives (FP) and false 
negatives (FN). We define the top 1 and top 2 metrics following Breneman 
and coworkers: the top 1 metric is the percentage of time that the best 
scoring site found by the model is experimentally validated as an SOM, while 
the top 2 metric is the percentage of time that one of the two best scoring 
sites has been experimentally validated as an SOM. Use of this metric 
enables direct comparison with the approach of Breneman and also other 
methods (MetaSite, Stardrop) that are reported in ref. [17, 18].  The second 
approach counts the number of predictions that agree and disagree with the 
experimental results, and thus is a comprehensive assessment of the 
accuracy and reliability of the methodology. 
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 For the first type of metric, all the candidates are first sorted by the local 
reactivity score. Then, for the candidates with the same local reactivity 
score, they are further sorted based on the energies calculated from the 
structural optimization stage.  
 
For the second type of metric, the evaluation stage is constructed by using 
cut-off on both the reactivity score and energy of the structure. All the top 2 
categories of atoms are considered as potential site of metabolism. Then a 
rejection based method is used to get rid of the bad candidates. For the top-
1 category of atoms from the reactivity score, if the corresponding energy is 
more than 50 kcal/mol higher than the lowest energy, this atom is rejected. 
For the atoms in the second category, if the corresponding energy is more 
than 20 kcal/mol higher than the lowest energy or the reactivity score is 
smaller than 1, this atom is rejected as well.  
 
The second type of metric is used when the first type of metric is not 
capable of distinguishing the difference of the results from different methods 
or stages, i.e. in the case where the top2 metric reach almost 100%. In the 
current simulation, due to the diversity and complexity of 3A4, only the first 
metric is used in the prediction of 3A4. For 2D6, since the top2 result of the 
training set already reaches an accuracy of 100%, both the first and second 
metric are evaluated.  
 
Put another way, we cannot expect the current sampling algorithm to be 
able to rigorously sampling the phase space of 3A4; the active site is too 
large, there are too many side chains that can adopt multiple rotamer 
conformations, and there is no anchor point, as there is in 2D6 to constrain 
the ligand. Our computational approach, and evaluation metrics, are 
designed to recognize this reality. In contrast, 2D6 has a much smaller 
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active site, and an anchor point in the salt bridge formation of a positive 
nitrogen on the ligand to GLU216/SER304. These factors drastically reduce 
the phase space available to any given ligand, and enable the induced fit 
methodology to provide a very large improvement in the accuracy of 
prediction for all sites on the molecule, including secondary (and less active) 
metabolic sites. Further work on both methodology and analysis of ligand 
binding modes for 3A4 will facilitate progress in moving towards results of 
the quality of those obtained here for 2D6.  
 
Application to different isoforms  
Despite the structural diversity of different isoforms, it is not optimal to 
construct from scratch a unique library of functional moieties for each 
isoform. Rather, the application to isoforms other than 3A4 will take the 
functional moieties library constructed for 3A4 as the base. Necessary 
modifications which account for the isoform related binding motifs can be 
added to the method used in 3A4. There are two considerations in deploying 
this kind of base-extension system. The first is because the underlying 
reaction is similar. Secondly, the data sets are small for certain isoforms. We 
choose 3A4 as the base because of (1) the large number of possible reaction 
pathways; (2) its large active site, which makes the training process for 
building the intrinsic reactivity model less affected by the protein side chains, 
thus the functional moieties can better represent the intrinsic reactivity and 
have better transferability. In the present study, 2D6 has chosen as the 
isoform to test the extension part of the current methodology.  There are 
two types of modifications in addition to the original base method. The first 
type is the modification that accounts for the salt bridge formation between 
GLU216/SER304 and the positive charged nitrogen on the ligand. The 
second type of modification is used to adjust the functional moieties. This 
	 18	
type of modification is learned from the reaction pathway difference between 
2D6 and the base isoform 3A4.  
 
 
3. Results 
3A4 
The data set used for the 3A4 case contains 384 ligands. This data set is 
basically the same as the one used in Breneman’s work[17], except that 
large ligands, which contain more than 60 heavy atoms, are not considered 
in current study, due to the difficulty to generate reasonable poses in 
induced fit docking. Modification of the induced fit docking algorithm to 
handle larger systems is possible and is planned in future work. For now, the 
vast majority of pharmaceutically relevant compounds have fewer than 60 
heavy atoms, and it is reasonable to ask what the results are for the data 
set when such cases are eliminated. 
 
 The PDB structure used for 3A4 is 3UA1 [37]. The overall results are 
summarized in Tables 1 and 2. In Table 2, 178 ligands are randomly chosen 
as the training set. The top 2 result is taken as the target during the 
parameter fitting process. Experiments with different random seeds, which 
generate different training sets, produced minimal variation in the results, as 
indicated by the standard deviation shown in Table 2. 
 
Table 1:  The overall results of 3A4 
 
Method TOP1 (%) TOP2 (%) 
RS Boltzmann a 60.7 78.2 
SMARTCypa 63.4 73.2 
RS-Predictor(TOP QC SCR) b 67.2 82.3 
Current Method 73.5±1.6 93.2±1.1 
(a) The data set[17] is the same as used in the current method except the extra-large ones. (b) The 
data set[18] is different than the current method by including ~90 more ligands, which contains the 
extra-large ones.  
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Table 2: The results of 3A4 
 TOP2 (%) 
Training  93.4±1.2 
Test  92.7±2.3 
Overall   93.2±1.1 
 
The results are compared with other method on the similar data set.  Most of 
the extra ligands used in the RS-Predictor(TOP QC SCR)[18] method are not 
drug like molecules. Therefore, these additional molecules are not tested in 
current method. For the top 2 metric, the best result reported for alternative 
methodologies is from RS-predictor, which is based on the RS Boltzmann 
consensus model, and reaches 78.2%[17]. The result from our method 
shows a ~ 15% improvement over RS-Predictor. With respect to the top 1 
metric, the best alternative performance is obtained by SMARTcyp[12], 
which reaches a rate of 64.6%. Our method can reach as high as 73.5%, 
which is ~ 9% better.  
 
The average computational time for prediction SOM in 3A4 is less than 1 
hour CPU time on a single 2.6 GHz AMD core. This is clearly unproblematic 
for late stage lead optimization applications (where a small number of 
compounds would be considered), and is viable for screening of tens or 
hundreds of thousands of compounds using a cluster of moderate 
computational capabilities. 
 
2D6 
The data set used to test 2D6 is the same data set that was used in our 
previous effort, IDsite[22]. All the ligands in the data set are believed to 
interact with the protein via one or more salt bridges, as described 
previously in the method section. The results are summarized in Table 3. 
The training set and the test set are the same as the ones used in IDsite. 
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The parameters developed for the reactivity model from the 3A4 data set are 
used to characterize the functional groups. The training set is mainly used to 
adjust the group partitions and to fit the salt bridge motif. In both the top 1 
and top 2 metrics, the current method gets very high prediction rates.  The 
actual numbers of true positives (TP), false positives (FP) and false 
negatives (FN) are provided in Table 4 and 5.  As noted above, this 
encompasses all sites of reactivity reported in the literature.  
 
Table 3:  The overall results of 2D6 
Metric Current Method (%) RS-WebPredictor (%) 
TOP1 (training set) 91.7 63.9 
TOP1 (test set) 85 65 
TOP2 (training set) 100 77.8 
TOP2 (test set) 95 80 
 
 
Table 4:  The training set results of 2D6 
Method TP FN FP 
Current Method 51 6 8 
IDsite 47 10 13 
IDsite fitted 52 5 8 
RS-TOP1 26 31 13 
RS-TOP2 35 22 49 
RS-TOP3 42 15 93 
RS-TOP1, RS-TOP2 and RS-TOP3 represent the results from RS-WebPredictor by using the top1, top2 
and top3 metric. 
 
 
Table 5:  The test set result of 2D6 
Method TP FN FP 
Current Method 24 1 8 
IDsite 21 4 8 
IDsite fitted 25 0 6 
RS-TOP1 14 11 7 
RS-TOP2 21 4 26 
RS-TOP3 21 4 47 
IDsite and IDsite fitted are from the previous work. RS-TOP1, RS-TOP2 and RS-TOP3 represent the 
same method, as described in Table 3. 
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To get a better understanding of our current results, the same data sets are 
used in RS-WebPredictor[38], which is the web service of RS-predictor. 
Table 4 and 5 summarized the results from IDsite, RS-WebPredictor and our 
method. In both tables, we can see that our current method gets similar 
results as the fitted IDsite does; these methods are close to precise 
reproduction of experiment. However, the present method has significantly 
reduced the computational time required. The average computational time 
for prediction SOM in 2D6 is less than 5 hour CPU time on a single 2.6 GHz 
AMD core. When comparing with the calculated results from the RS-
WebPredictor, the present method is qualitatively better in terms of all the 
TP, FP and FN, by an order of magnitude or more depending upon exactly 
what metrics are used to make comparisons.  These results demonstrate 
that, as docking accuracy increases, the power of an explicit structure based 
component of the model becomes much larger, and leads to highly reliable 
SOM identification. 
 
Results at different stages 
The induced fit effects for both 3A4 and 2D6 are summarized in Table 6 and 
7. For 3A4, the prediction rates increase by more than 9 percent, giving that 
the prediction rate from the reactivity score function is already as high as 
83.9%. For 2D6, the induced fit effects are also important, as shown in 
Table 7. The number of TP increase by more than 20% for both the training 
and test set.  
 
Table 6:  The results of 3A4 at different stage 
Stage  TOP1 TOP2 
Without minimization 65.9±1.1 83.9±0.4 
After minimization 73.5±1.6 93.2±1.1 
The results without minimization are calculated by using the local reactivity score only. 
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Table 7:  The results of 2D6 at different stage 
Type No induced Fit Minimization  Sampling 
TP(training) 39 49 51 
FN(training) 18 8 6 
FP(training) 3 13 8 
TP(test) 18 24 24 
FN(test) 7 1 1 
FP(test) 4 10 8 
No induced Fit: results are calculated by using the local reactivity score only. Minimization: results are 
calculated by only using the energy from the minimization of the docked poses. Sampling: the results 
are calculated by using the full protocol as described in the method. 
 
 
4. Discussions 
Functional groups 
Among all the functional groups used, there are several types that are  the 
most important. Table 8 provides the top 2 most important functional groups 
in the secondary as well as the correctional types. One obvious feature is 
that they are all very simple groups. The nitrogen atom, which is not in the 
conjugated system, can help the oxidation process in different ways, as 
mentioned in the method section. The oxygen atoms mainly help the 
reaction by stabilizing the carbon radical through lone pair. The top 2 
correctional groups are interesting. The first one is the methyl group. On one 
hand, the correctional methyl group is related to the dealkylation type of 
oxidations. On the other hand, a target connected with the methyl group is 
usually at a very flexible position of the ligand. Thus, it is more correlated 
with the positive reaction sites than negative reaction sites. The carbonyl 
group usually acts to reduce the positive effects of the secondary group 
through conjugation. Therefore, the correctional carbonyl group is more 
correlated with negative sites than positive ones.  		
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Table 8: The top2 most important secondary and correctional functional 
groups 
 Structure Frequency(total 384)  
First secondary   N (not in conjugated 
system) 
202 
Second secondary  -O- 155 
First correctional -CH3 137 
Second correctional C=O 106 
 
Induced Fit effects 
Even though the intrinsic reactivity plays the most important role in the case 
of 3A4, the induced fit calculation is also indispensable to get a satisfactory 
prediction rate. For the current data site, about 116 ligands need to go 
through the induced fit calculation, which further improves the top 2 metric 
result from 83.9% to 93.2%. Figure 5(a) and (b) shows two minimized 
poses of arachidonic_acid docked into 3A4 structure (PDB code: 3UA1). By 
taking into consideration induced fit effects, the candidate structure in Figure 
5 (a) has a more favorable conformation than the candidate in Figure 5(b). 
It is clear that the two strong salt bridges formed between the protein and 
the carbonate in Figure 5(a) play a significant role in selecting the correct 
pose. One is constructed with the backbone of PHE213 and the other is 
constructed with the side chain of ARG212. For the candidate in Figure 5(b), 
only one salt bridge is observed with GLU374. The distance between the 
oxygen and hydrogen is larger than the ones in Figure 5(a).  
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	(a)				
			 (b)		
Figure 5:  The docked pose of arachidonic_acid in P450 3A4. The color scheme is: pink(oxygen), 
white(hydrogen), yellow(sulfur), orange(iron), green(carbon). (a) pose for positive. (b) pose for 
negative. The red dotted line with number shows the connection of the formed salt bridge between the 
ligand and protein. The red dashed line without number connects the oxo and target atom of the 
ligand. 
	 25	
 
The importance of induced fit can be further analyzed by examining the 
actual conformational change of the sampled region. Figure 6 shows the 
structures before the minimization stage in 3A4 for the ligand 
arachidonic_acid. Comparing with minimized structure shows in Figure 5(a), 
it is clear that the protein underwent conformational change to better 
interact with the ligand, as indicated by the large oxygen-hydrogen distance 
changes in the salt bridge regions.  
 
		 																																								(a)																																																																																			(b)		
Figure 6: (a) The docked pose of Figure 5(a) before minimization.  (b) Ligand structure after 
minimization combined with protein structure before minimization. The red dashed line with number 
shows the connection of the formed salt bridge between the ligand and protein.  Color scheme is the 
same as that in Figure 5.  
 
In the case of 2D6, the induced fit calculations have a larger impact on 
prediction accuracy due to the relatively small active site size. As show in 
Table 5, the number of TPs has increased from 68.4% to 89.5% for the 
training set, and from 72% to 96% for the test set. At the same time, the 
number of FPs has only increased by 5 for the training set and 4 for the test 
set.  
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A detailed examination of the actual minimized structures sheds more light 
on how the induced fit simulations help to increase the observed number of 
true positives. The minimized structure of mexiletine docked into the 2D6 
(PDB code: 2F9Q) is illustrated in Figure 7. Both Figure 7(a) and (b) show 
the docked poses for the true positives. In Figure 7(a), the candidate has a 
better reactivity score than the one in Figure 7(b). However, by taking into 
account the induced fit effect, the candidate in Figure 7(b) has a lower 
energy as indicated by the three salt bridges between the protein and the 
ligands. Therefore, both of these candidates are picked as positives.  
 	
											 																																	(a)																																																																																											(b)		
Figure 7: The docked pose of mexiletine in P450 2D6. (a) pose for positive with better reactivity score. 
(b) pose for positive with worse reactivity score. The red dotted line with number shows the 
connection of the formed salt bridge between the ligand and protein. The red dashed line without 
number connects the oxo and target atom of the ligand. Color scheme is the same as that in Figure 5 
with blue purple representing the positively charged nitrogen.  
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5. Conclusions 
In the current study, we present a novel method to accurately and efficiently 
predict the sites of metabolism in reactions of drug-like molecules with the 
P450 isoforms 3A4 and 2D6. The multiple stage method that we have 
developed allows a flexible and accurate incorporation of both the intrinsic 
reactivity as well as the suitability of the ligand conformation for reaction, 
including induced fit effects. The contribution of the docking/induced fit 
component to the prediction accuracy is substantially larger in the case of 
2D6, where the relatively small active site and presence of a salt bridge 
constraint allow robust structural prediction, than for 3A4, where the large, 
highly flexible active site presents severe challenges for current flexible 
docking methods; nevertheless, significant benefit to the docking component 
is seen even for the 3A4 case. For both isoforms, improvements as 
compared to purely ligand based methods are observed, with the largest 
improvement unsurprisingly being obtained for 2D6.  The computation time 
is such that deployment at various stages of structure based drug design 
projects should be routine. 
 
The results for 2D6 provide, in these retrospective studies, highly precise 
predictions.  Further validation of the method requires one or more of the 
following; (a) prospective prediction of SOMs, confirmed by experiment; (b) 
confirmation of the structural models, which is possible via NMR experiments; 
(c) evaluation using larger and more diverse data sets. If the results hold up 
to these tests, the 2D6 model can be considered a useful practical solution 
to the prediction of 2D6 SOMs. 
 
As discussed above, the 3A4 model will require significantly more work to 
get to this point.  The key here is improving the structural prediction 
methodology for 3A4.  Experimental information concerning 3A4 binding 
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modes (again possibly obtained from NMR measurements) would be of great 
help in achieving this goal.  However, better sampling algorithms and 
scoring functions may also be required. The task is a challenging one and it 
will require significant effort to make progress; the 2D6 results provide a 
target level of performance that one could hope to reach with a better 
protocol. 
 
Finally, we intend to extend the present approach to a complete suite of 
P450 isoforms, including other significant enzymes such as 2C9.  The 
remaining isoforms are more like 2D6 in that the active sites are not as 
larger as 3A4, and the binding motifs are better defined.  Thus, we are 
optimistic that performance similar to that for 2D6 can be achieved for these 
additional isoforms. If this is the case, the overall improvement across all 
isoforms for SOM prediction will be significant, and can potentially make a 
valuable contribution to drug discovery projects in which modification of 
metabolic behavior is an issue. 
 
 
 
 
	  
	 29	
Supporting Information  		
Type	 Functional	groups	
Primary	 C	(	further	classified	by	aromaticity,	number	of	connected	H	and	certain	ring	structure	)		N	(	further	classified	by	aromaticity	and	number	of	connected	H	)		S	(oxidation	number	<	+4,	further	classified	by	aromaticity)				P	(bonded	with	S)				
Secondary	 -CH3	(contribution	depends	on	the	number	of	CH3)			-F			N-C=O		(contribution	depends	on	the	connected	primary	groups)		-O-			(contribution	depends	on	the	number	of	O)			Nonaromatic	6/5-member	ring	with	O		6/5-member	ring	with	one	carbon	double	bonded	to	O			
Benzisoxazole-like structure 		N	in	aromatic	ring		C=C		-N-	(not	in	conjugated	system);				N-N			C=C-C=O			-S-		N-C=S			N-C≡N		
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	N-C=N		
			
			
		
	(	contribution	depends	on	the	connected	primary	groups)		
			
			
	(contribution	depends	on	the	connected	primary	groups)				
Correctional	 C=O	(		contribution	depends	on	the	connected	primary	and	secondary	groups)	
	 31	
	-O-		-OH		C=C		O-C=O	(	contribution	depends	on	the	connected	primary	and	secondary	groups)			-Cl		-CH3		-N-	(not	in	conjugated	system)			
			
		
	 (contribution	depends	on		whether	the	primary	group	is	in	the	ring)			
		
(contribution	depends	on	the	connected	primary	groups)		
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				 Table	S1,	List	of	functional	groups	used	in	the	case	of	3A4.	
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